Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Read more at CNBC
-
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.CNBC - 23h -
Weight Loss Drugs and Their Lesser Known Side Effects on Relationships
Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy.The New York Times - 4d -
Americans split on using weight loss drugs to treat obesity: Survey
Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a survey published Friday. The new Associated Press (AP)-NORC ...The Hill - 5d -
NFL Draft 2025: Shrine Bowl takeaways and standouts, including a QB who could be taken earlier than expected
With Shedeur Sanders sitting out, Kyle McCord was the top-performing QBCBS Sports - Jan. 27 -
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.CNBC - Jan. 24 -
Weight-loss drugs may boost health in many ways, say researchers
New weight-loss drugs have broad health benefits but also come with risks, researchers warn.BBC News - Jan. 20 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - Jan. 17 -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - Jan. 13 -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - Jan. 13
More from CNBC
-
How Calvin Klein and Tommy Hilfiger got caught in Trump's trade war with China
The owner of Calvin Klein and Tommy Hilfger has been placed on China's unreliable entities list, which could force it to cease operations in the region.CNBC - 2h -
Trump's tax cuts are 'stuck in the mud' as Republicans split over spending
Fiscal hawks are demanding deeper cuts on major tax, energy and healthcare package that would advance key Trump administration priorities.CNBC - 1h -
Judge pauses Trump federal employee buyout offer pending court hearing
A lawsuit says the Trump administration's offer of a buyout to federal employees is unlawful, noting that Congress has not appropriated money for it.CNBC - 8m -
Bank stocks pop after Fed releases 'easier' 2025 stress test, plans to make exam more predictable
The stress test changes bolster the case made by Wall Street analysts that U.S. banks will face a friendlier regulatory regime under the Trump administration.CNBC - 41m -
Amazon set to report earnings after the bell
The company is expected to show strong operating income growth, reflecting CEO Andy Jassy's efforts to rein in expenses.CNBC - 2h
More in Business
-
Southern California Edison acknowledges videos suggest link between equipment and Eaton fire
However, the Edison International unit has not identified evidence to confirm this, according to a filing with the California Public Utilities Commission.CNBC - 8m -
Feds ease up on stress tests, agree on need for bank-access fix
Bank stocks rise as KBW analysts praise ‘less stressful’ bank stress tests.MarketWatch - 8m -
Judge pauses Trump federal employee buyout offer pending court hearing
A lawsuit says the Trump administration's offer of a buyout to federal employees is unlawful, noting that Congress has not appropriated money for it.CNBC - 8m -
The top 10 'hidden gem' ZIP codes in America—these are 'fast-developing' areas, says new report
Opendoor ranked the ZIP codes based on the increase in number of new listings from January 2024 to November 2024 on a ZIP code level.CNBC - 9m -
BoE’s grim outlook highlights scale of the challenge for Rachel Reeves
UK central bank has forecast weaker growth, higher inflation and rising unemploymentFinancial Times - 18m